ResearcherUniversity of HohenheimActive in the last 2 years
Markus Burkard
Matched on ORCID iD 0000-0001-6113-2275; OpenAlex author ID A5051780774.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Collaborators
- 7
2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 5
- Progress and challenges in the development of advanced pancreatic cancer organoids. Last author DOI 10.1186/s13046-026-03717-3↗
- Role of iron and TfR1 in the application of high‑dose ascorbate against pancreatic cancer. Co-author DOI 10.3892/or.2026.9083↗
- The therapeutic potential of vitamins A, C, and D in pancreatic cancer. Co-author DOI 10.1016/j.heliyon.2024.e41598↗
- Chemovirotherapy for pancreatic cancer: Gemcitabine plus oncolytic measles vaccine virus. Co-author DOI 10.3892/ol.2019.10901↗
- Novel epi-virotherapeutic treatment of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus. Co-author DOI 10.3892/ijo.2016.3675↗
Closest collaborators
The 7 strongest of 7 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Sascha Venturelli · 5 shared papers, 2016–2026
- Paper Progress and challenges in the development of advanced pancreatic cancer organoids. DOI 10.1186/s13046-026-03717-3↗
- Paper The therapeutic potential of vitamins A, C, and D in pancreatic cancer. DOI 10.1016/j.heliyon.2024.e41598↗
- Paper Role of iron and TfR1 in the application of high‑dose ascorbate against pancreatic cancer. DOI 10.3892/or.2026.9083↗
- Alban Piotrowsky · 3 shared papers, 2025–2026
- Paper Progress and challenges in the development of advanced pancreatic cancer organoids. DOI 10.1186/s13046-026-03717-3↗
- Paper The therapeutic potential of vitamins A, C, and D in pancreatic cancer. DOI 10.1016/j.heliyon.2024.e41598↗
- Paper Role of iron and TfR1 in the application of high‑dose ascorbate against pancreatic cancer. DOI 10.3892/or.2026.9083↗
- Luigi Marongiu · 3 shared papers, 2025–2026
- Paper Progress and challenges in the development of advanced pancreatic cancer organoids. DOI 10.1186/s13046-026-03717-3↗
- Paper The therapeutic potential of vitamins A, C, and D in pancreatic cancer. DOI 10.1016/j.heliyon.2024.e41598↗
- Paper Role of iron and TfR1 in the application of high‑dose ascorbate against pancreatic cancer. DOI 10.3892/or.2026.9083↗
- Katja Detert · 2 shared papers, 2026
- Ulrich M. Lauer · 3 shared papers, 2016–2026
- Paper Progress and challenges in the development of advanced pancreatic cancer organoids. DOI 10.1186/s13046-026-03717-3↗
- Paper Chemovirotherapy for pancreatic cancer: Gemcitabine plus oncolytic measles vaccine virus. DOI 10.3892/ol.2019.10901↗
- Paper Novel epi-virotherapeutic treatment of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat w… DOI 10.3892/ijo.2016.3675↗
- Verena Larissa Josefine Ilse May · 1 shared paper, 2019
- Tim Patrick Ellerhoff · 1 shared paper, 2016
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.